Pharma wholesaler Salus sees H1 net profit edge down on higher revenues

Ljubljana, 31 August - Pharmaceuticals wholesaler Salus saw its sales revenues rise by 6.6% to EUR 107.8m in January-June compared to the same period last year. On the other hand, net profit edged down by 0.7% to EUR 1.85m, the company said in a press release published on the website of the Ljubljana Stock Exchange on Wednesday.